Atlas Trials

Efficacy Study of Dasatinib in Locally Advanced Triple-Negative Breast Cancer Patients

Clinical trial NCT00817531 · TERMINATED

Trial details

NCT number
NCT00817531
Sponsor
Baylor Breast Care Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2008-12-01
Primary completion
2011-02-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.